NAMPT is able to regulate the pathogenesis of obesity and related diseases, especially NAFLD, by affecting lipid and glucose metabolism, inflammation and apoptosis [44]. The gene discussed is NAMPT; the disease is metabolic dysfunction-associated steatotic liver disease.